Location History:
- Malle, BE (2015 - 2016)
- Westmalle, BE (2017 - 2020)
Company Filing History:
Years Active: 2015-2020
Title: Jan Marie Cyriel Jozef Hoflack: Innovator in Cancer Imaging and Treatment
Introduction
Jan Marie Cyriel Jozef Hoflack is a notable inventor based in Westmalle, Belgium. He has made significant contributions to the field of medical imaging and cancer treatment through his innovative patents. With a total of four patents to his name, Hoflack's work focuses on enhancing the diagnosis and treatment of various cancers.
Latest Patents
Hoflack's latest patents include a groundbreaking invention titled "Radiolabeled macrocyclic EGFR inhibitor." This invention relates to 18-Fluor radiolabeled macrocyclic quinazoline compounds, which serve as positron emission tomography (PET) tracers for imaging epidermal growth factor receptors (EGFR). These tracers are crucial for in vivo diagnosis, preclinical and clinical tumor imaging, and patient stratification based on the mutational status of EGFR. The invention is particularly relevant for cancers influenced by deregulated EGFR, including non-small cell lung cancer, pancreatic cancer, and breast cancer, among others.
Another significant patent is the "Macrocyclic salt-inducible kinase inhibitors." This invention involves macrocyclic compounds that act as inhibitors of SIK kinase, specifically SIK1, SIK2, and SIK3. These compounds are intended for use in the diagnosis, prevention, and treatment of diseases associated with SIK kinase. The methods provided in this patent can be utilized as medicines or diagnostic agents.
Career Highlights
Hoflack is currently associated with Oncodesign SA, a company dedicated to advancing cancer research and treatment. His work at Oncodesign has positioned him as a key player in the development of innovative solutions for cancer diagnosis and therapy.
Collaborations
Hoflack collaborates with esteemed colleagues, including Petra Marcella Francoise Blom and Pascal Andre Rene Benderitter. Their combined expertise contributes to the advancement of research in the field of oncology.
Conclusion
Jan Marie Cyriel Jozef Hoflack is a distinguished inventor whose work has the potential to transform cancer diagnosis and treatment. His innovative patents reflect a commitment to improving patient outcomes and advancing medical science.